Alector Licenses AL050 to Genentech for $100M Upfront
Alector granted Genentech exclusive global rights to develop and commercialize AL050. Alector will receive $100M upfront and is eligible for up to $1.17B in milestones, plus tiered royalties.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.